$650 million judgement against Walgreens and other drug stores, though a December ruling in Ohio appeals court upended the penalty and will likely render it invalid.
CNBC’s David Faber said Walgreens' rumored sale to Sycamore Partners appeared "mostly dead a couple of weeks ago" but he was now upgrading the deal to "alive." ...
We’ve reached a point where the current pharmacy model is not sustainable ... “With these closures, Walgreens will render ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback